Attualita in tema di terapia antiipertensiva dell'anziano

Translated title of the contribution: Recent news on antihypertensive therapy in the aged

A. Rappelli, P. Dessi-Fulgheri

Research output: Contribution to journalArticle

Abstract

High blood pressure is the main cardiovascular risk factor even in the elderly. In particular, with aging, elevated systolic blood pressure becomes more important as a risk factor than does diastolic blood pressure both in males and in females. This epidemiological consideration, derived mainly from studies such as the Framingham Study, has been confirmed by several therapeutic international trials on high blood pressure in the elderly (e.g.) the Veteran Administration Cooperative Study on Antihypertensive agents, the Australian Therapeutic Trial in Mild Hypertension, the European Working Party on Blood Pressure in the Elderly, the SHEP Study and the STOP-Hypertension. These trials have demonstrated that pharmacological treatment of hypertension reduces cardiovascular mortality and morbidity even in elderly patients. However, further studies are necessary to evaluate the effects of other drugs, such as calcium antagonists, angiotensin converting enzyme inhibitors and the new angiotensin II receptor antagonists.

Original languageItalian
Pages (from-to)483-487
Number of pages5
JournalGiornale di Gerontologia
Volume44
Issue number8-9
Publication statusPublished - 1996

Fingerprint

Antihypertensive Agents
Blood Pressure
Hypertension
Therapeutics
United States Department of Veterans Affairs
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Pharmacology
Calcium
Morbidity
Mortality
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Ageing
  • Geriatrics and Gerontology

Cite this

Rappelli, A., & Dessi-Fulgheri, P. (1996). Attualita in tema di terapia antiipertensiva dell'anziano. Giornale di Gerontologia, 44(8-9), 483-487.

Attualita in tema di terapia antiipertensiva dell'anziano. / Rappelli, A.; Dessi-Fulgheri, P.

In: Giornale di Gerontologia, Vol. 44, No. 8-9, 1996, p. 483-487.

Research output: Contribution to journalArticle

Rappelli, A & Dessi-Fulgheri, P 1996, 'Attualita in tema di terapia antiipertensiva dell'anziano', Giornale di Gerontologia, vol. 44, no. 8-9, pp. 483-487.
Rappelli A, Dessi-Fulgheri P. Attualita in tema di terapia antiipertensiva dell'anziano. Giornale di Gerontologia. 1996;44(8-9):483-487.
Rappelli, A. ; Dessi-Fulgheri, P. / Attualita in tema di terapia antiipertensiva dell'anziano. In: Giornale di Gerontologia. 1996 ; Vol. 44, No. 8-9. pp. 483-487.
@article{4c0b21e98f4a4076bac29ae0e98029b7,
title = "Attualita in tema di terapia antiipertensiva dell'anziano",
abstract = "High blood pressure is the main cardiovascular risk factor even in the elderly. In particular, with aging, elevated systolic blood pressure becomes more important as a risk factor than does diastolic blood pressure both in males and in females. This epidemiological consideration, derived mainly from studies such as the Framingham Study, has been confirmed by several therapeutic international trials on high blood pressure in the elderly (e.g.) the Veteran Administration Cooperative Study on Antihypertensive agents, the Australian Therapeutic Trial in Mild Hypertension, the European Working Party on Blood Pressure in the Elderly, the SHEP Study and the STOP-Hypertension. These trials have demonstrated that pharmacological treatment of hypertension reduces cardiovascular mortality and morbidity even in elderly patients. However, further studies are necessary to evaluate the effects of other drugs, such as calcium antagonists, angiotensin converting enzyme inhibitors and the new angiotensin II receptor antagonists.",
keywords = "antihypertensive drugs, elderly, hypertension, systolic hypertension",
author = "A. Rappelli and P. Dessi-Fulgheri",
year = "1996",
language = "Italian",
volume = "44",
pages = "483--487",
journal = "Giornale di Gerontologia",
issn = "0017-0305",
publisher = "Pacini Editore s.r.l.",
number = "8-9",

}

TY - JOUR

T1 - Attualita in tema di terapia antiipertensiva dell'anziano

AU - Rappelli, A.

AU - Dessi-Fulgheri, P.

PY - 1996

Y1 - 1996

N2 - High blood pressure is the main cardiovascular risk factor even in the elderly. In particular, with aging, elevated systolic blood pressure becomes more important as a risk factor than does diastolic blood pressure both in males and in females. This epidemiological consideration, derived mainly from studies such as the Framingham Study, has been confirmed by several therapeutic international trials on high blood pressure in the elderly (e.g.) the Veteran Administration Cooperative Study on Antihypertensive agents, the Australian Therapeutic Trial in Mild Hypertension, the European Working Party on Blood Pressure in the Elderly, the SHEP Study and the STOP-Hypertension. These trials have demonstrated that pharmacological treatment of hypertension reduces cardiovascular mortality and morbidity even in elderly patients. However, further studies are necessary to evaluate the effects of other drugs, such as calcium antagonists, angiotensin converting enzyme inhibitors and the new angiotensin II receptor antagonists.

AB - High blood pressure is the main cardiovascular risk factor even in the elderly. In particular, with aging, elevated systolic blood pressure becomes more important as a risk factor than does diastolic blood pressure both in males and in females. This epidemiological consideration, derived mainly from studies such as the Framingham Study, has been confirmed by several therapeutic international trials on high blood pressure in the elderly (e.g.) the Veteran Administration Cooperative Study on Antihypertensive agents, the Australian Therapeutic Trial in Mild Hypertension, the European Working Party on Blood Pressure in the Elderly, the SHEP Study and the STOP-Hypertension. These trials have demonstrated that pharmacological treatment of hypertension reduces cardiovascular mortality and morbidity even in elderly patients. However, further studies are necessary to evaluate the effects of other drugs, such as calcium antagonists, angiotensin converting enzyme inhibitors and the new angiotensin II receptor antagonists.

KW - antihypertensive drugs

KW - elderly

KW - hypertension

KW - systolic hypertension

UR - http://www.scopus.com/inward/record.url?scp=0030435212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030435212&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0030435212

VL - 44

SP - 483

EP - 487

JO - Giornale di Gerontologia

JF - Giornale di Gerontologia

SN - 0017-0305

IS - 8-9

ER -